Diflucan Bioequivalence Study For Transferring The Manufacture
Status:
Completed
Trial end date:
2019-03-06
Target enrollment:
Participant gender:
Summary
This study is to assess the bioequivalence between fluconazole 50mg capsules from two
different manufacturers. This is a open-label, randomized, single dose, 2-treatment, 2-period
crossover study in healthy Korean male and female subjects aged 19-55, to assess the
bioequivalence after taking study drugs.